Stock TXMD THERAPEUTICSMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
1.88 USD -0.79% Intraday chart for TherapeuticsMD, Inc. +1.08% -16.44%
03-29 TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-06 Knight Therapeutics Announces Launch of Bijuva in Canada MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Reinstates TherapeuticsMD at Neutral With $5 Price Target
MT
HC Wainwright Downgrades TherapeuticsMD to Neutral From Buy
MT
Cantor Fitzgerald Downgrades TherapeuticsMD to Neutral From Overweight, Adjusts Price Target to $1 From $5
MT
HC Wainwright Adjusts Price Target on TherapeuticsMD to $3 From $4, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXMD Stock
  4. News TherapeuticsMD, Inc.
  5. Analyst Reco.